Formic Acid

Formic Acid

SCHEMBL25252000

COCCOCCOCCOCCOCCOCCOc1ccc(Cl)cc1-c1ccc2c(NCc3ccc(OC)cc3OC)nnc(C)c2c1.O=CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 18/20 0.41
CYP3A4 P08684 18/20 0.41
CYP2C19 P33261 17/20 0.41
ALDH1A1 P00352 12/20 0.41
CLK4 Q9HAZ1 12/20 0.41
HSD17B10 Q99714 12/20 0.41
CYP2C9 P11712 11/20 0.41
TSHR P16473 11/20 0.41
LMNA P02545 10/20 0.41
MAPT P10636 2/20 0.39
CYP2D6 P10635 16/20 0.39
USP2 O75604 9/20 0.39
MAPK1 P28482 8/20 0.39
HIF1A Q16665 7/20 0.39
KDM4E B2RXH2 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
HPGD P15428 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALOX15 P16050 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30467709 1.00 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL24252817 0.93 CYP1A2 (0.46) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL30451335 0.86 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL24252742 0.86 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
Formic Acid SCHEMBL30451433 0.86 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
Formic Acid SCHEMBL25207554 0.86 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL30467568 0.85 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL24252850 0.85 CYP1A2 (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL30467617 0.85 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
Formic Acid SCHEMBL25242377 0.83 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2024-04-04 US disclosed
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 CYP1A2 2977/4885CYP3A4 2694/4885CYP2C19 1687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.